Speakers

Prasad Adusumilli is a thoracic surgeon-scientist and Vice Chair of Translational Research in Dept. of Surgery at the Memorial Sloan Kettering Cancer Center, New York. His research focuses on solid tumor immunology and immunotherapy. Supported by R01 and Dept of Defense awards, his laboratory...

Krishna Allamneni is an accomplished executive with a proven track record of success in the biopharmaceutical industry. Currently serving as the Executive Vice President and Chief Development Officer at Concarlo Therapeutics Therapeutics, she provides strategic leadership by guiding the p27...

Sonia Appel has over 20 years of experience in Technical Operations, from commercial molecular diagnostics to pharmaceutical early development.  With a Master of Science in Molecular Biology and a Project Management Professional (PMP) certification, she has led multiple development strategies, IND ...

Founder and CEO of Precision Biologics (2012), board-certified medical oncologist, on clinical staff at the National Cancer Institute (NCI) and Walter Reed Medical Center, Co-Chair for the National Institutes of Health (NIH) Institutional Review Board (IRB). Medical degree (MD) 1991, Medical...

Fouad Atouf, Ph.D., is Senior Vice President, and Head of the Biologics Program at the United States Pharmacopeia (USP) where he oversees standards development, stakeholder engagement and industry collaborations, all in support of ensuring the quality and safety of biological medicines. Dr. Atouf...

Aniket Badkar has extensive experience in the pharmaceutical industry, with a focus on biologics drug substance and drug product formulation development. Aniket currently holds the position of Director of Formulation and Drug Product Development at Vir Biotechnology, Inc. In this role, they lead...

Matthew Bernett, Ph.D. has been at Xencor, Inc. for over 19 years, and is currently an Executive Director in the Protein Engineering group where he has been involved in all aspects of the company’s research efforts. Accomplishments include being a co-inventor of tafasitamab (Monjuvi) as well as...

Eddy Berthier is a Principal Scientist in Pharmaceutical Development Biologics Drug Products at Lonza. With over 18 years of extensive experience in the biopharmaceutical industry, Eddy has worked across various stages from research to commercial GMP manufacturing, specializing in downstream...

Dr. Shiva Bhowmik is the Founder + Chief Scientific Officer at TRIO Pharmaceuticals, Inc.. He is a pioneer in targeted protein and antibody therapeutics, including the development of TRIO’s platform. He is also a recognized expert in the fields of immuno-oncology, antibody, and protein...

In her role as the Scientific Engagement Lead for Johnson & Johnson Innovation – JLABS West North America, Natalija is responsible for external engagement with regional academic research institutions, start-ups and investment partners to shape strategic opportunities for Johnson &...

At Genovac, Iwona leads the single B-cell antibody discovery technology group where she is responsible for the development of processes on and around Bruker Cellular Analysis’ Beacon platform for the discovery of antibodies against challenging targets. Iwona earned her PhD from the...

Steven Calciano is a Business Development Manager at SCIEX for Biopharmaceutical Analysis supporting Capillary Electrophoresis (CE) and Mass Spectrometry (MS) products. He has over 10 years of experience in commercial organizations, holding roles in sales, marketing, and product management for...

​​​​​​​Allyson is currently a Process Development Scientist at Amgen. Presently, she conducts cell based and immune assays to understand CQAs impact immunogenicity. She serves as an Immunogenicity and Flow Cytometry subject matter expert supporting Amgen pipelines, products, and patients. Prior to...

Dr. Prasun Chakraborty is the CEO and Founder of Genevation/GeneevationUS, a groundbreaking biotechnology company pioneering the development of personalized cancer vaccines. Dr Chakraborty is a visionary leader and innovator in the field of biotechnology, specializing in the development of...

Javier joined Pfizer in 2007 and is leading the BioTherapeutic Discovery department within Biomedicine Design. He is responsible for leading biotherapeutic discovery work, including lead generation and optimization, biophysical characterization, and non-GLP biotherapeutic production. During his...

Dr. Qiang “Shawn” Chen is a molecular biologist who specializes in developing novel human therapeutics and vaccines in plants to combat infectious diseases, cancer, and biological warfare reagents. His research aims to ameliorate diseases and improve human health, as well as to contribute new...

Dr. Jake Chen is the Associate Director and Chief Bioinformatics Officer of the Informatics Institute, Professor of Genetics, and the chief of Informatics Section of the Genetics Department at the UAB School of Medicine. Chen has been studying bioinformatics—the science of...

Dr. Judy Chou is the CEO and President of AltruBio, Inc. which is a clinical stage biotech company in San Francisco, CA. Before taking on her current roles, she headed the global Biotech organization at Bayer Pharmaceuticals overseeing the development, manufacturing and distribution of Bayer’s...

Pamela Reilly Contag, PhD Over 25 years Pamela Contag has built a career as an academic researcher, biopharmaceutical entrepreneur, and senior executive. Dr. Contag’s current immune-oncology company, BioEclipse, is completing a phase 1 trial in ovarian cancer with an autologous TCR cell-based...

Douglas is Director of Purification, Analytics and CMC for the Drug Creation function at Absci, where he and his team seeks the advancement of AI-designed therapeutic antibodies from early-stage research to IND and FiH studies. His team is responsible for generation and analysis of proteins at...

Brandon J. DeKosky joined the Department of Chemical Engineering as an assistant professor in a newly introduced joint faculty position between the department and the Ragon Institute of MGH, MIT and Harvard in September 2021. He received his BS in chemical engineering from University of Kansas, and ...

Brad Delaney is an associate manager of business development at Nona Biosciences. He has worked previously as a scientist for Nona where he performed the first campaigns for heavy chain and multispecific antibody, CAR-T, and T cell engager discovery using Nona’s HCAb Harbour Mice®. Additionally, he ...

Andrew received his B.S. in Chemistry from Boston College in 2008, and his Ph.D. in Biological Chemistry from Massachusetts Institute of Technology in 2012. Since completing his thesis work, he has been part of the Biotherapeutics and Genetic Medicine department at AbbVie in Worcester, MA. Focusing ...

Koen Dierckx has over 20 years of experience in R&D, pharmaceutical operations and project management. He has an executive MBA and holds a Master’s degree in Civil Engineering and Biochemistry from the University of Leuven. He has worked for Sanofi, where he held several positions in...

Robert O. Dillman, M.D. is a Clinical Professor of Medicine at the University of California Irvine and since 2016 has been the Chief Medical Officer of AIVITA Biomedical Inc., Irvine, CA. For 25 years, he directed the Hoag Cancer Center in Newport Beach, CA, where he also served as scientific...

Raymond has over 25 years’ experience in the pharmaceutical industry ranging from basic R&D to prescribing use of pharmaceuticals.  He has experience of working in the public and private sectors including small biotech and the service industry.  Over the past decade his focus has mainly been in ...

Rebecca Driscoll is a seasoned healthcare executive with over 25 years of experience in cancer diagnostics and oncology. She is the Co-Founder of Cancer Help Desk, a nonprofit dedicated to providing real-time education, testing, and treatment access for cancer patients. Before this, Rebecca founded ...

Ashley Driscoll-Kani is a Global Regulatory Strategist with more than 10 years of experience currently working in the non-viral liver therapeutic space. She has previously worked in immunology and oncology on a variety of biologic therapies in the US and EU. She has worked on several marketing...

Mary Dwyer, PhD, is a scientific director with over 15 years of expertise in biologics drug discovery, specializing in antibody platforms and multi-specific formats. She has led groundbreaking initiatives, including establishing VHH discovery platforms and directing over 20 therapeutic antibody...

Madison Ford is a Research Analyst at the Center, where she conducts grant-funded research involving survey and database design, quantitative and qualitative data analysis, and literature reviews. She earned her BS in Public Health from The University of Alabama and her MPH in Health Management and ...

Gordon Freeman, PhD, Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, is renowned for discovering the PD-L1 and PD-L2 proteins. Dr. Freeman showed that PD-L1 and PD-L2 bound to PD-1 to turn off the immune response and that blockade of PD-L1/PD-1 enhanced immune...

Shanelle Gabriel is a lupus patient advocate, poet and communications connections expert from Brooklyn, NY. She has spoken and performed on countless global stages from Lincoln Center to the Vatican to the National Press House. She has crafted artistic messaging for brands and companies including...

Armine is a tech ecosystem builder and VC investor with eight years of experience in driving operational strategy and tech community development. Armine’s expertise lies in cultivating high-impact partnerships, building a community of tech executives, founders and investors and supporting companies ...

Dr. Gee is Vice President, Head of Research at 3T Biosciences. He is co-founder of 3T Biosciences and an internationally recognized expert and pioneer in the field of pHLA targeting via T cell receptors and bispecific T cell engagers. Dr. Gee brings more than a decade of domain expertise across the ...

Steve Glavas is responsible for Global Sales at Magic Bioprocessing, a high performance magnetic bead provider for antibody, protein, and molecular production at scale. He has extensive experience in business development, commercialisation, and biotechnological applications, including DNA...

Holding her PhD in biochemistry with over 10 years of experience in developing biologics for pharma companies, Dr. Gontarz is our resident expert in global analytical and process development, as well as formulation sciences. Currently, Dr. Gontarz is the Head of the Scientific and Technical Affairs ...

Davis Goodnight is a Senior Scientist in Platform R&D at A-Alpha Bio, where he works in developing platform technologies to generate massive protein-protein interaction datasets and leveraging these datasets for a variety of therapeutic protein engineering efforts. He earned his Ph.D. in...

Marshall is a molecular pharmacologist with four years in the industry leading pre-clinical gene therapy programs from discovery to IND-enabling studies. He is currently a principal scientist at Nysnobio developing a novel gene therapy for Parkinson's Disease. 

Christilyn Graff, Senior VP and Head of Research at Mosaic, is a biotech leader with 20+ years in biologics drug discovery, specializing in protein and antibody engineering. Previously Senior Director at Biogen, she expanded the biologics portfolio in oncology, neurology, immunology, and...

David is a Senior Scientist in Protein Engineering at Merck, he has worked with bispecific antibodies in various formats for multiple therapeutic areas over the last 5 years. Before joining Merck he received his Master’s degree in Biochemistry and Structural Biology from Cornell University, where...

Dr. June Guo serves as the Vice President of Artificial Intelligence and Machine Learning and co-leader of the computational platform at Athos Therapeutics Inc. June leads strategies and development on AI/ML-powered software platform which accelerates the whole process of precision medicine...

Joanna Guo, Ph.D., is a cancer cell biologist specializing in the discovery and development of small molecule drugs and antibody drug conjugates. As a key member of the Translational Biology team at Zentalis Pharmaceuticals, she plays an integral role in biomarker identification and drug...

Sanjeev Gupta has obtained Ph.D. in Cell Line Engineering and M.Sc. in Applied Microbiology and Biotechnology. Also received Honorary Professorship award from Amity University, MH (Feb., 2024). At present working as Sr. Vice President and BU Head-Biosimilar Division (R&D, Mfg. and Business...

Abhinav Gupta joined Large Molecule Research at Sanofi in August 2022 as a Senior Machine Learning Scientist, AI Innovation for Antibody. Abhinav received his PhD in Mechanical Engineering and Computation from MIT where he developed state-of-the-art algorithms and methodologies for uncertainty...

Trae Hampton earned a BS in Biochemistry at the University of Dallas in 2018. During his undergraduate career, he investigated novel synthetic pathways for silylated tetrahydropyrans as a summer researcher under Prof. Asunción Barbero at the University of Valladolid in Valladolid, Spain. At the...

Net Haskins, M.S. is a Scientist II at Amgen, specializing in antibody discovery and optimization. She holds master’s degrees in Biological Sciences from the University of Maryland and Biochemistry and Molecular Biology from Georgetown University. Her current role involves co-leading biologics...

Michael Hedvat is Director of Discovery Bioloy at Xencor, Inc., where he leads development of novel therapeutics in oncology and autoimmunity. Prior to joining Xencor, Dr. Hedvat was a research scientist in the translational oncology group at Kyowa Hakko Kirin, CA. He received his B.S. at...

Jonas brings more than 10 years experience in biotechnology and antibody engineering to Tubulis and secured several prestigious start-up awards for the company. Prior to co-founding Tubulis, Jonas was a Group Leader at the Ludwig-Maximilians University (LMU) in Munich. He also co-founded ChromoTek...

Chris has over 20 years of experience in drug product development, cGMP/GLP analytical method development, validation, and stability. He has led diverse projects and initiatives, including drug development, bioassay/biophysical characterization testing, investigations, and cGMP/FDA regulatory...

Björn Hock is Biochemist and Chief Development Officer of Tubulis. Before joining Tubulis, Björn worked for Aerium Therapeutics, Ferring Pharmaceuticals and Merck KGaA where he held various positions in the Biotherapeutics space. In addition to his role at Tubulis, Björn is founder and principal...

Kyle Hoffman completed his PhD in Biochemistry at Western University and his postdoctoral fellowship with Professor Dieter Soll at Yale University. During this time Kyle focused on mass spectrometry-based proteomics and protein engineering with non-canonical amino acids. Kyle is currently the...

Rob has over 25 years’ experience in Drug Discovery and early-stage Development. After obtaining his PhD in Molecular Medicine at UCL, he was post-doctoral researcher at The University of York before to Cambridge Antibody Technology where he was a Senior Scientist within Antibody Engineering then...

Changyun (Eric) Hu is CSO of Adept Therapeutics Inc, a biotech company focusing on developing antibody-mediated immunotherapies for cancer patients. Changyun's effort has contributed to several patents and multiple IND filings and is known for his expertise in antibody drug discovery against...

Karin A. Hughes, Ph.D. is a distinguished executive in regulatory, clinical, and quality affairs for in vitro diagnostics (IVDs), with over 30 years of experience advancing healthcare innovation through precision diagnostics. As Senior Vice President of Global Regulatory & Quality at...

Janani Iyer leads AI/ML Product at Absci Corporation, a biotech company that leverages generative artificial intelligence to improve biologics drug discovery. She supports Absci’s AI Research, Engineering, Computational Biology, and Wet Lab Screening teams in their collective efforts to develop...

Dr. Jingjing Jiang is the Senior Director of Development Sciences at Bambusa Therapeutics, a biotech company specializing in bispecific antibodies for immunology and inflammation. With expertise in translational research and development sciences, she has a strong track record of building R&D...

I am a proteomics scientist at Johnson & Johnson in the Cell Engineering and Analytical Sciences group. My mission at J&J is to leverage proteomics to drive innovations that will lead to the next generation of CHO hosts for bioproduction through cell engineering. My graduate work was at the ...

Dr. Mo Kagalwala received his Ph.D. in Biochemistry and Molecular Biology from the Southern Illinois University School of Medicine and MBA from UCSD Rady School of Management.  Dr. Kagalwala completed postdoctoral fellowships at MD Anderson Cancer Center and the Salk Institute. In 2020, he moved to ...

Derrick Katayama is a lead scientist in the formulation group at Samsung Biologics, where he manages multiple biological molecule formulation projects. Derrick has over 15 years of experience in the biopharmaceutical industry and has held various positions at companies such as Amylin...

Dr. Keyt is CSO of Multivalent Biosciences and has also served as Chief Scientific Officer of IGM since August 2012 and previously served as a consultant beginning in August 2010. Prior to joining us, Dr. Keyt served as Chief Technology Officer at Trellis Bioscience, an antibody discovery...

​​​​​​​Dikran Khachadourian is a Field Application Scientist at Halo Labs. Dikran completed his undergraduate studies at UC San Diego, obtaining a bachelor's degree in Biochemistry and Cell Biology. His interest in the biological sciences led him to pursue a master's degree in...

Emilee gained her PhD in Infectious Diseases and Microbiology from the University of Pittsburgh under the direction of Prof. Charles Rinaldo, identifying immune responses to lytic infection with Human Herpes Virus-8 and the role of cytokines in the pathogenesis of Kaposi’s Sarcoma  She joined...

Srikanth earned his PhD in Medicinal and Pharmaceutical Chemistry from the University of Minnesota, Twin Cities. He currently serves as an Associate Director at Neurocrine Biosciences, San Diego, leading a team dedicated to developing bioanalytical methods using LBA and LC-MS for Pharmacokinetic...

Zoran Krunic, Senior Manager of Data Science, Amgen   Since joining Amgen R&D in 2018, Zoran Krunic has been at the forefront of applying Machine Learning to enhance patient outcomes and streamline clinical trial enrollment processes, utilizing comprehensive Electronic Health Records and...

I. My Story in a NutshellSince my birth, I have lived around the globe (Tanzania, Singapore, Thailand, Chile, USA, etc.), got my higher educational degrees in USA, and later joined the University of Tokyo as faculty in the Department of Bioengineering. My past achievements include my original...

Sam Lai, Ph.D., was born in Hong Kong and spent his childhood in both Hong Kong and Vancouver. After completing high school at Phillips Academy, Andover, he attended Cornell University and received his BS in Chemical and Biomolecular Engineering in 2003. He then undertook doctoral studies at Johns...

Dr. Jin Lee is the CEO of IMIDeology, a medical clinic for patients with chronic inflammation and autoimmune conditions.  Dr. Lee worked in the venture and innovation arms of pharma, payer, and provider space- responsible for product and commercialization. Dr. Lee is also an investor in three angel ...

My academic training began in 1998 as an undergraduate at UBC, where I immersed myself in the Combined Honours Physics and Mathematics Program, graduating as a Canada Scholar and recipient of the CK Choi Presidential Award. In 2002, I moved to UC Berkeley as an NSERC fellow to pursue doctoral...

John Lesnick is a senior field applications scientist at  Sphere Bio and a leader in single-cell analysis and microfluidic technology. He has over 15 years at the bench discovering therapeutics, providing extensive systems cellular biology and cell-based assay development experience. He has...

Shawn Levy is a seasoned professional in the biotechnology industry, currently serving as the Senior Vice President of Scientific Affairs at Cellanome. With over 20 years of experience in the field, Shawn has a proven track record of driving innovation and leading successful research and...

Yinyin Li got her PhD degree from Texas A&M university and completed postdoc training at Stanford University, where she focused on innate and adaptive immune response in autoimmune and inflammatory disease. Currently, she is a Principal Scientist in the Biochemical and Cellular Pharmacology...

Dr. Haining Li is a recent graduate of the University of California San Diego, where she earned her PhD in Bioengineering under the mentorship of Dr. Nathan Lewis. Her doctoral research focused on developing innovative approaches for glycan analysis and understanding the impacts of glycoengineering ...

John Lippincott (“Lippy”) is Senior Vice President of Therapeutic Discovery Strategies at Alloy Discovery Services. He has over two decades of experience in the generation and characterization of antibodies from in vivo systems.Prior to joining the deeply experienced team at Alloy, Lippy...

John Lippincott (“Lippy”) is Senior Vice President of Therapeutic Discovery Strategies at Alloy Discovery Services. He has over two decades of experience in the generation and characterization of antibodies from in vivo systems.Prior to joining the deeply experienced team at Alloy, Lippy...

Dr. Gang Liu is the Associate Director of Biointron. He has devoted himself to biological research sciences and antibody therapeutics research for more than 20 years. Before joining Biointron, Dr. Liu worked in renowned biotech companies and institutions, including Children's Hospital LA, UC...

Wenshe Ray Liu is the Harry E. Bovay, Jr. Endowed Chair and Professor in Chemistry at Texas A&M University. He earned his B.S. degree from Peking University in 2000 and his Ph.D. degree under the direction of Prof. Michael D. Toney from UC-Davis in 2005. He finished a two-year postdoc training...

Cate Lockhart, PharmD, PhD is the Chief Science Officer of the Academy of Managed Care Pharmacy (AMCP) and the Executive Director of the Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) where she is responsible for all AMCP research programs, including those within the BBCIC...

Anne Lynch is a dedicated and results-driven Research Associate at Hologic, with a passion for advancing the field of biologics. With a strong background in molecular biology and biotechnology, Anne brings a wealth of knowledge and expertise to her role. She has a proven track record of conducting...

M.D, Ph.D; Serve as Associate Director at Zentalis Pharmaceuticals, leading oncology drug development from early discovery through IND, and translational-clinical stage. Experience in small molecule drug discovery, PROTAC/degrader, and deep understanding of diverse modalities, including antibody...

For nearly 20 years Scott Mack has performed research on the electrophoretic analysis of biologic compounds, primarily concentrating on the application of isoelectric focusing.  He joined SCIEX after the acquisition of Intabio, where he coinvented and lead application development of their...

Dr. Mark Mamula is Professor of Medicine, Yale University School of Medicine, and Founder of TheraJan, LLC (therajan.com), a company developing canine cancer immunotherapies.  Dr. Mamula’s interests are in investigating the early events of inflammatory mediated changes in the proteome that...

Cheryl has over 25 years of experience in the pharmaceutical and biotech industry, specializing in clinical quality. She is currently the Head of Clinical Quality Assurance at Immunovant. Her expertise includes audits, inspections, quality issue management, risk management, and quality oversight. ...

Dr. Spencer Marsh is the Chief Scientific Officer of The Tiny Cargo Company, a biotechnology startup company headquartered in Roanoke, Virginia. Dr. Marsh has a Ph.D. In Biomedical Engineering from Clemson University, with a focus in extracellular vesicle drug delivery, which is the driving...

Nicholas Marshall, PhD, adds a diverse background in protein biochemistry, biophysical characterization, protein engineering, and process development to Invenra. As the leader of the Protein Sciences group, Nick oversees production and characterization of R&D phase molecules, including...

Shamekka Marty is a Cybersecurity Project Management Consultant, Foundation Director, and board member of several charitable organizations. She is a dedicated wife, mother of three, Lupus survivor, and mentor, whose advocacy has touched many lives across the globe. Her caregiving journey began at...

Chris Mason MD, PhD, FRSB, FRCS, FMedSciChris has over 30 years of cell and gene therapy experience spanning R&D, clinical medicine, manufacturing, and commercialization. He is a Full Professor of Cell & Gene Therapy at University College London. Chris is also a serial...

I'm a writer, editor, and publishing executive with more than 35 years of experience in clinical, health policy, managed markets/payer, and pharmaceutical sectors. I have worked extensively as a consultant to the health care communications industry and publishers, as well as project manager for ...

Matthew joined Oxford Biotherapeutics in 2022 as a program manager. He is dedicated primarily to external innovation, coordinating and delivering target validation data for partnership programs, and business development, developing content and strategies for current and future partnerships. He...

Marco Mirata leads the Manufacturing Science and Technology organization for Microbial Operations at Lonza. With nearly 15 years of experience in the biopharma and biotech sectors, he has held technical and leadership roles in Innovation, R&D, Process Development, and Operations within the...

Liviu Movileanu has received his Ph.D. degree in biophysics from the University of Bucharest (1997). He has acquired postdoctoral positions at the University of Missouri (Kansas City, Missouri, 1997-1998) and the Texas A&M University Health Science Center (College Station, Texas, 1999-2004). He ...

Savita Nair, Ph.D., is an accomplished scientist and Associate Director at Sangamo Therapeutics, where she leads the CMC Bioassay Analytical Development group within Technical Operations in Brisbane, California. With a focus on product quality characterization, she has successfully guided her team...

Professor Niazi is a pioneer of biosimilars, having created the term with extensive experience of advising the FDA, EMA, MHRA, the US Senate, and the White House on legislation related to biosimilars; he has been able to bring many changes that now make biosimilars affordable. He established the...

Dr Yemi Onakunle is an accomplished biopharmaceutical industry expert with over twenty-five years of experience. He is the co-founder and CEO of Mabswitch Inc., a company focused on developing regulatable next-generation immunotherapies based on antibody affinity switches. Prior to Mabswitch, he...

Digital drug hunter active in artificial intelligence and knowledge management for target and drug discovery. Two drugs in clinical trials: R-ketorolac for in ovarian cancer, and LNS8801, a first-in-class orphan drug designated GPER agonist for uveal melanoma. Conceptual developments in disease and ...

Vincent Pai is Director of Product Management at Bruker Cellular Analysis. He has over 10 years of expertise in cell biology, nanotechnology, and microfluidics, with research experience from UC San Diego and Massachusetts General Hospital in Boston. He joined Berkeley Lights in 2016 and...

Bill co-founded rarekidneycancer.org with Dr. James Hsieh in 2016 after being diagnosed with a meningioma and p1RCC (a rare kidney cancer) in 2014 . In 2018 and 2020, with Pete Kane, he brought together 17 teams of more than 80 researchers who used his medical data to determine “genes of interest”...

After being diagnosed with a meningioma and p1RCC (a rare kidney cancer) in 2014, Bill co-founded rarekidneycancer.org with Dr. James Hsieh in 2016.  In 2018 and 2020, with Pete Kane, he brought together 17 teams of more than 80 researchers who used his medical data to determine “genes of interest” ...

Dr. Ravish Patel holds a Ph.D. from Nirma University and brings 18 years of extensive experience in the biopharmaceutical industry, specializing in Biosimilars, Vaccines, Plasma-derived Proteins, Cell and Gene Therapy, and CMC Characterization & Quality (QMS). Throughout his career, Dr. Patel...

Lauri is a trained molecular biologist, who turned into the interesting path of proteomics and machines that go ‘ping’ (read – MS) during the later years of his PhD studies. After post-doc years in Edinburgh and then a few more back home in Tartu, Lauri left academia for private sphere, joining the ...

With a passion to serve patients, Chad Pettit has joined Amgen’s Global Government Affairs and Policy team with extensive commercial, biosimilar, and policy expertise. In this role he will continue to elevate the important role biosimilars play in health system sustainability and advocating for...

Chayne Piscitelli is a Principal Scientist and Group Lead at Zymeworks, Inc., where he works amongst a diverse team of protein engineers in early research and development of multi-specific antibody therapeutics. Prior to Zymeworks, Chayne was a postdoctoral fellow at ETH Zürich and the Paul...

Alejandro Preciado is a business development leader in biopharma, specializing in process development, manufacturing, and analytical services for biologics and bioconjugates. As Senior Director of Business Development, Biologics at KBI Biopharma, he partners with biotech innovators to advance...

Dr. Alexei Pushechnikov is an accomplished scientific and technology leader with over two decades of experience in drug discovery, medicinal chemistry, and process research. Throughout his career, Dr. Pushechnikov has held senior roles across the biotech and pharmaceutical ecosystem in the United...

Leon Pybus, PhD is a member of the Global Innovation team at FUJIFILM Diosynth Biotechnologies, where he leads the development of the company’s next generation CHO expression and upstream processing technologies. Leon holds a PhD from the University of Sheffield and has over ten years of industrial ...

Maryam Raeeszadeh-Sarmazdeh joined the University of Nevada, Reno in July 2019 as an assistant professor. Her research group is focused on biomolecular engineering and synthetic biology to develop novel biotechnology tools and products to solve major issues in human health, sustainability and...

Allison Ramiller designs incentive competitions at XPRIZE Foundation. XPRIZE competitions catalyze innovation and technology breakthroughs across several domains, including health. She is currently focused on approaches to promote health in women across the lifespan. Prior to joining...

Sathya is currently responsible for providing subject matter expertise and guidance to support teams with RBQM implementation and contributing to the evolution of RBQM capabilities at Gilead. In his prior roles, he has driven business and product vision, strategy, and execution by liaising with the ...

Udaya Rangaswamy is Director of translational biology at Rondo therapeutics, a start-up focused on novel multi-specific engagers for solid tumors. Prior to Rondo, Udaya was a Principal Scientist at Amgen following Amgen’s acquisition of Teneobio in 2021. Between both Amgen and Teneobio, Udaya has...

Jeff Rapp obtained his B.S. in microbiology at the University of Notre Dame in 1986, then received a Ph.D. in biochemistry from Texas A&M University in 1993. His first postdoc was in the Herpes Branch at the CDC in Atlanta, from 1993-1995. Jeff’s second postdoc was in Lois Miller’s lab in the...

Christopher Robertson joined the BU Law faculty in 2020 as a tenured professor and N. Neal Pike Scholar in Health & Disability Law. Robertson previously served as associate dean for research and innovation and professor of law at the University of Arizona. Professor Robertson is an expert in...

Christy has more than 15 years of policy experience in Washington, DC. A principal at the economic policy consulting firm Matrix Global Advisors (MGA) since 2019, she joined the firm in 2010. At MGA, Christy advises clients, writes reports and white papers, and constructs economic models. She has...

Mr. Rongen is a serial entrepreneur and R&D / Commercial Development leader with extensive experience across many therapeutic areas and functions. Currently, he is Co-Founder and Board Member of a new MSKCC spinout Oncology Company, CEO of neuroscience/gene-therapy company of Adolore...

Mr. Rongen is a serial entrepreneur and R&D / Commercial Development leader with extensive experience across many therapeutic areas and functions. Currently, he is the CEO of neuroscience/gene-therapy company of Adolore BioTherapeutics, Co-Founder and Board Member of a new MSKCC spinout...

Brandon T. Ruotolo is currently a Professor in the Department of Chemistry, University of Michigan. He earned his B.S. in Chemistry from Saint Louis University in 1999. Brandon then received his Ph.D. from Texas A&M University in 2004 under the direction of David H. Russell. He did his...

 Dr. Md Abu Zafor Sadek is serving as Deputy General Manager of UniMed UniHealth Pharmaceuticals, Bangladesh. He has 19 years career in pharmaceutical product management and training with high degree of creative mindset. Also, he worked for The World Bank, Dhaka Office, Bangladesh as Short-term...

Giorgio is part of the Business Unit, with responsibility of coordinating Business Development and Post sales activitiesHe joined BSP Pharmaceuticals in 2008 as Manufacturing Manager; in this role he was an active member of the team in charge of building up the manufacturing plant, including...

Volker Schellenberger co-founded Amunix in 2006 and served as Chief Scientific Officer. He is the lead inventor of the company’s XTEN as well as XPAT platforms of protease-activated T cell engagers. Since the acquisition of Amunix by Sanofi in 2022, Volker directed discovery at Sanofi’s center of...

PRISM was founded in 2009 by Dr. Schnitzer, a world-renowned expert in vascular biology with almost four decades of research experience.  Upon earning his MD in 1985 from the University of Pittsburgh, he served as a Post-Doctoral Fellow in the Department of Cell Biology, Yale University Medical...

Dr. Alessandro Sette has devoted more than 35 years in biotech and academia to understanding and measuring immune responses, and developing disease intervention strategies against cancer, autoimmunity, allergy, and infectious diseases.  Dr. Sette’s laboratory is the world leader in the study of the ...

Yang Shen, Ph.D., joined Regeneron in 2018 and currently serves as Executive Director, Antibody Engineering in Bispecific Department and Co-Chair of Protein Therapeutics, Pipeline & Technology Section at Regeneron. Yang founded Antibody Engineering Group and played instrumental role in...

​​​​​​​Lei Shi, PhD. is an SVP at Biointron. Prior to that, he worked for a series of biotech companies, including Virtuoso Therapeutics, Zai Lab, and Bird Rock. Lei had also worked at J&J in antibody discovery technology. He completed his Postdoc study at MGH and Harvard Medical School.

Diane Simeone, MD, is a an internationally recognized surgeon who has a long-standing practice in the treatment of pancreatic neoplasms. She has an active clinical practice in pancreatic cancer and the management of pancreatic cystic tumors and high risk individuals. Dr. Simeone is the director of ...

Angela Specht is the Global Head, BARDA Alliance for Johnson & Johnson Innovation. In this role, Angela leads BLUE KNIGHT™, a joint initiative between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response ...

Pawel is Tanvex CDMO's Process and Drug Product Development director, bringing nearly two decades of experience in early R&D, as well as early and late stage of process development to Tanvex. Pawel started his career at The Scripps Research Institute, working under legendary Nobel Prize...

Prior to joining Twist Bioscience, Sam served as a Senior Scientist in the In-Vitro Antibody Discovery team at Sanofi, a global pharmaceutical company. During his time at Sanofi, he contributed to the development of innovative approaches for antibody discovery, leveraging in vitro techniques to...

Dr. Sumner leads INOVIO’s clinical-stage pipeline of DNA medicines, global clinical development, clinical operations and biostatistics efforts, as well as regulatory affairs, pharmacovigilance and medical affairs. Dr. Sumner previously served as CMO of Orexo AB and held numerous European- and...

Adeleh Taghi Khani is an accomplished scientist with over five years of experience in Immunology and immunogenicity, specializing in therapeutic areas like oncology and autoimmunity. Currently a Scientist II at Quest Diagnostics, she excels in developing immunogenicity assays and strategies, and...

Shreehas is Chief Executive Office and Managing Director, and a Member of the Board of Directors of Biocon Biologics, a leading global biosimilars company committed to enabling affordable access to lifesaving biosimilars globally.He has been with the Biocon Group for over 27 years and has held...

Dr. Keenan Taylor is a Principal Research Scientist I at AbbVie in the Protein Science group within Biotherapeutics and Genetic Medicine. He is responsible for the construct design, purification, and delivery of research-grade proteins/antigens to advance the Biologics Discovery pipeline.

Dr. Thakur's research activities are focused on 1) developing new and innovative therapeutic approaches to enhance clinical and anti-tumor immune responses; 2) developing novel strategies to attenuate the immune suppressive cellular and humoral factors.

Dr. Jakub Tomala earned his Master Science degree and Ph.D., both in Immunology, at Charles University in Prague, Czech Republic. After completing a postdoctoral fellowship at Johns Hopkins University, School of Medicine, in 2018, Dr. Tomala became senior researcher in the Laboratory of...

Andrew Tsourkas, Ph.D. is a Professor and Undergraduate Chair of Bioengineering at the University of Pennsylvania.  He received his Bachelor’s degree in Mechanical Engineering in 1997 from Cornell University and his Ph.D. in Biomedical Engineering from the Georgia Tech/Emory University joint...

Ross Turmell is a Principal Scientist in the Cytiva Manufacturing Science and Technology organization.  Ross specializes in aseptic bulk drug processing design and the incorporation and use of filtration products.  Ross has held technical leadership and bulk  processing positions at Pall...

Vaishnav is the Founder & CEO of Sequome, a company that decodes & designs sequences to develop Sequence Medicines, working with Fortune 500 Pharmaceutical & Technology companies. Prior to Sequome, Eeshit received his PhD from MIT as a Presidential Fellow, where he was advised by...

Hans van der Vliet, M.D., Ph.D. is chief scientific officer of LAVA Therapeutics. Dr. van der Vliet is also a professor in medical oncology at the Amsterdam UMC in the Netherlands. He received his medical doctor degree from the University of Amsterdam in 1998, his doctor of philosophy degree (cum...

Sudhakar Voruganti is Business Development Director at Pfanstiehl, a world’s leading manufacturer of low endotoxin and high purity GMP parenteral grade carbohydrate based excipients for biopharmaceuticals. At Pfanstiehl he provides commercial and technical support to the Biopharma...

Kim Walker, MS, RAC (US & EU), FRAPS kawalker@sdsu.edu kimwalkerconsulting@gmail.com www.kimwalkerconsulting.com www.linkedin.com/in/kimwalkerconsulting   Consulting Work Kim Walker is an independent Global Regulatory Affairs, Quality System, and Clinical Affairs Consultant and owner of ...

Jenny Wei is the Head of R&D Informatics and Technology at Kite Pharma. She has over 24 years of experience in biopharma industry building digital strategy, delivering AI/ML solutions & advanced analytics to accelerate small molecule, biologics, and cell therapy research & clinical...

David Wood is a professor of Chemical Engineering at the Ohio State University and has been working on intein technology for close to 25 years.  He has also worked in industry at Amgen and BMS, and has developed a number of useful tools through multidomain protein engineering.

Aiying Yu is a Senior Scientist in the BioAnalytical Sciences Department at Genentech since 2022. She received her Ph.D. in Analytical Chemistry from Texas Tech University. She is experienced in comprehensive structural identification and quantification of proteins, glycans, and glycopeptides in...

Dr. Samuel Zhang is currently Chief Business Officer (CBO) of Innovent Biologicals. Dr. Zhang has over 20 years of industry experience across the entire drug research, development and commercialization spectrum. He has a successful track record in identifying emerging industry trends and promising...

Dr. Jing Zhang is an Assistant Project Scientist in Dr. Farah Sheikh lab at University of California-San Diego. Her work focus on the gene therapy approach for the arrhythmogenic cardiaomyopathy, which is a genetic based cardiac disease with the mutations asociated with cardiac cell-cell junctions.

Dr. Yue Zhao earned her Ph.D in Biochemistry and Molecular Biology from Peking Union Medical School, China. Her graduate work discovered the NOD-like receptors(NAIPs) for recognizing cytosolic bacterial pathogens. She continued working in the innate immunity space and made several phenomenal...

Dr. Zhao has almost 20 years of experience in biomarker research and drug development in both academic and industry settings. She earned her Ph.D. in Bioinformatics from the University of Oslo, Norway, with a focus on breast cancer genomics. During her post-doctoral training at Stanford...

Sheng Zhong is a Professor of Bioengineering at UC San Diego and the founder and CEO of Genemo, Inc. Genemo is a biotechnology company focused on pioneering exRNA-based diagnostics for early disease detection and personalized medicine. Our proprietary SILVER-seq technology analyzes extracellular...

Alla leads technical applications and marketing at Cygnus Technologies. Alla joined Cygnus Technologies in 2017 bringing 17 years of experience in product development and management in the bioprocessing industry. Prior to Cygnus Technologies, Alla spent several years at Semba Biosciences leading...